A two-part phase I study of ALB 127158A in healthy volunteers and patients with obesity.

Trial Profile

A two-part phase I study of ALB 127158A in healthy volunteers and patients with obesity.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs ALB 127158A (Primary)
  • Indications Obesity
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 01 Jun 2011 Topline results have been reported in a AMRI media release.
    • 01 Jun 2011 Status changed from recruiting to completed.
    • 22 Jul 2010 This trial is expected to be complete in the first quarter of 2011, according to an AMRI media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top